AstraZeneca’s scientific leadership in respiratory diseases on display at ATS2016
From 13-18 May, physicians and researchers from around the world will come together to discuss cutting-edge science and advances in respiratory disease management at the American Thoracic Society (ATS) International Conference San Francisco, California.
This year, AstraZeneca is presenting a wide range of data across our leading respiratory portfolio. Data reflect advancements across novel inhaled therapies, respiratory biologics and new pathways aimed at underlying disease.
Follow us on Twitter @AstraZeneca or stay tuned to this page for news, a behind-the-scenes look at the science, and all the latest from San Francisco.
Following the science: Our strong heritage and future in Respiratory
Watch this new video to learn more about AstraZeneca's commitment to respiratory disease medicine and the millions of patients worldwide who are living with asthma and chronic obstructive pulmonary disease (COPD).
Atlas ID: 979423.011
Date of next review: May 2017